Comparison of post-traumatic changes in circulating and bone marrow leukocytes between BALB/c and CD-1 mouse strains

Authors: Tanja Spenlingwimmer aff001;  Johannes Zipperle aff001;  Mohammad Jafarmadar aff001;  Marcin Filip Osuchowski aff001;  Susanne Drechsler aff001
Authors place of work: Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria aff001
Published in the journal: PLoS ONE 14(9)
Category: Research Article
doi: 10.1371/journal.pone.0222594


This manuscript emerged from a larger third-party funded project investigating a new poly-trauma model and its influence upon secondary sepsis. The present sub-study compared selected leukocyte subpopulations in the circulation and bone marrow after polytrauma in BALB/c versus CD-1 mice. Animals underwent unilateral femur fracture, splenectomy and hemorrhagic shock. We collected blood and bone marrow for flow cytometry analysis at 24h and 48h post-trauma. Circulating granulocytes (Ly6G+CD11+) increased in both strains after trauma. Only in BALB/c mice circulating CD8+ T-lymphocytes decreased within 48h by 30%. Regulatory T-cells (Tregs, CD4+CD25+CD127low) increased in both strains by approx. 32%. Circulating Tregs and lymphocytes (CD11b-Ly6G-MHC-2+) were always at least 1.5-fold higher in BALB/c, while the bone marrow MHC-2 expression decreased in CD-1 mice (p<0.05). Overall, immune responses to polytrauma were similar in both strains. Additionally, BALB/c expressed higher level of circulating regulatory T-cells and MHC-2-positive lymphocytes compared to CD-1 mice.


Biology and life sciences – Cell biology – Cellular types – Animal cells – Blood cells – White blood cells – T cells – Lymphocytes – Immune cells – Bone marrow – Anatomy – Body fluids – Blood – Physiology – Genetics – Heredity – Inbreeding – Medicine and health sciences – Immunology – Immune system – Immune physiology – Research and analysis methods – Animal studies – Experimental organism systems – Inbred strains – Model organisms – Mouse models – Animal models


Each year, approximately 11 million laboratory animals are used in Europe [1]. Mice account for approximately 70% of all animals used in preclinical research including critical care medicine making them the most frequently used species [2]. Generally, inbred strains such as BALB/c and C57BL/6 belong to the most frequently utilized [3]. There are strong arguments in favor of inbred strains; their relatively stable genetic uniformity [4] improves experimental reproducibility simultaneously increasing statistical power and reducing the total number of animals (the 3R rule). Additionally, the massive amount of genetic information available for inbred strains eases genetic manipulations and facilitates selection of mice with exact genetic characteristics desired for a defined experiment [5]. In toxicity testing, the use of small cohorts of inbred strains has been recently recommended [4,5]. In the last years, however, the importance of using genetically heterogeneous organisms in experiments has been stressed given that they better mimic the heterozygosity of the human population. The Diversity Outbred and Collaborative Cross mice initiative is an example of this attention shift [6]. The use of outbred mice allows a better insight into whether and/or to what extent the genotype influences the host response to disease. Outbred mice are commonly used in studies investigating malignancy and immunological responses to pathogens and/or drugs, aimed at recapitulating the diversity of human reactions to diseases and medications used to treat them [710].

Not many evaluations between inbred and outbred mouse strains were performed; the existing studies investigated conditions such as diabetes, bone marrow transplantation and obesity [1116]. The vast majority of pre-clinical mouse studies on trauma were performed in inbred strains [12,17,18] and an available inter-strain comparison was performed among the inbred strains only [19].

Best to our knowledge, only two inbred versus outbred comparisons were performed in acute trauma models [20,21]. Another three [16,20,22] from the broad critical care field compared inbred to outbred mice demonstrating marked inter-strain differences in the investigated endpoints. For example, Richardson and Kuhn [16] demonstrated that inbred mice (compared to outbred) were typically more heterogeneous in their reactions to a cholera enterotoxin stimulus; several inbred strains (e.g. C3H, CBA, DBA) were less responsive than outbred (e.g. Swiss-Webster (CFW) strains. Cahill et al. [22] demonstrated that permeability of the blood-spinal cord barrier after severe peripheral nerve injury was approximately two-fold higher in CD-1 compared to BALB/c mice.

The above studies indicate that differences in immuno-inflammatory sequelae between the outbred and inbred strains are likely and should be accounted for in the context of study design in trauma modeling. Therefore, in a prequel to a larger study that investigated an influence of a new polytrauma model upon secondary sepsis [23], we compared the inbred and outbred mouse strains. Hence, this is not a stand-alone experiment, but it was designed in conjunction with the above project.

In the present study, we investigated whether the genetic hetero- and homogeneity of BALB/c vs. CD-1 mice subjected to polytrauma influenced subsequent immunological responses of selected leukocyte subpopulations in the circulating and bone marrow leukocyte compartment.

Material and methods


12 weeks old, female BALB/c (n = 60) and CD-1 (n = 33) mice (Charles River Laboratories, Sulzfeld, Germany) were used for the experiment, the exact n/group distributions are shown in the figure legends. Upon arrival all animals were allowed to acclimatize to their new environment for at least 7 days. Mice were kept in groups of 5 per type III cage, housed under a 12h light-dark diurnal cycle with a controlled temperature of 22°C to 24°C. Standard rodent diet and water were provided ad libitum throughout the experiment. Enrichment was provided (houses, wooden boards, wood wool and tissues for nesting) to facilitate natural behavior.

Ethical statement

All animal procedures were approved by the Viennese (Austria) legislative committee (Animal Use Proposal Permission No. 343130/2013/14) and conducted according to the National Institutes of Health guidelines. These experiments were not stand-alone but aimed at selecting the most suited mouse strain for a large third-party funded research project [23]. The comparison of the immune responses to polytrauma between inbred and outbred mouse strains provided the basis to investigate the effect of the post-traumatic immunologic changes in the large project.

During the experiment mice were monitored by trained professionals several times a day to ensure their well-being, combining the observation of clinical symptoms with measurements of body weight and body temperature. Body weight and temperature remained within the range of the guidelines set by the Viennese legislative committee. All experiments were sublethal. Animals were euthanized by using deep inhalation anesthesia with isoflurane followed by cervical dislocation.

All surgical procedures were executed under inhalation anesthesia with isoflurane (2–3%, Forane®, Baxter, Austria). Analgesia (buprenorphine, 0.05 mg/kg, s.c., Bupaq®, Richter Pharma, Austria) was administered twice a day until the end of the experiment. Pre-existing baseline data from healthy BALB/c mice were included to reduce the number of animals to a minimum.

Experimental design

BALB/c and CD-1 mice (in n = 10 per group iterations) were subjected to trauma (unilateral femur fracture), splenectomy and hemorrhagic shock (TSH). Either 24h or 48h later animals were euthanized to collect blood and bone marrow. The 24h and 48h time-points were chosen to detect protracted immunologic deterioration that can potentially influence the progression of (secondary) sepsis.

Polytrauma model (TSH)

Trauma was induced by a closed unilateral mid-shaft fracture of the left femur with custom built blunt pliers, followed by hemorrhagic shock induced by a loss of 30% of total blood volume (calculated as 6% of the body weight) via retroorbital puncture under additional local anaesthesia (Oxybuprocainhydrochlorid, Novain®, AGEPHA Pharma, Austria).

Splenectomy was performed as follows: the left side of the abdomen was shaved and disinfected using betaisodona® solution. To open skin and abdominal cavity a 5mm incision was made. The spleen was carefully exposed. Before the removal of the spleen afferent and efferent blood vessels were ligated using Silkam® USP 4/0. Abdomen was closed with single button sutures and the skin using the Histoacryl® adhesive. Mice were resuscitated subcutaneously with four times of the shed blood volume, ¼ immediately post TSH, the remaining ¾ 1h post-TSH. All surgical procedures and the post-traumatic phase were covered with potent analgesia (0.05 mg/kg buprenorphine s.c., Bupaq®, Richter Pharma, Austria, twice daily until the end of the experiment).

Blood samples

The first blood sample was taken at induction of trauma from shed blood (retroorbital puncture), the second one was collected via vena cava with a syringe rinsed with K3EDTA either 24h or 48h post-TSH.

Bone marrow collection

Bone marrow was collected from the right femur and tibia. The epiphyses were cut off and the bones were flushed with 3ml cold PBS using a 23G needle. Collected bone marrow was gently pipetted through a 45 μm cell strainer and spun down at 300 x g for 10 mins. The pellet was resuspended in 2 mL lysis buffer (multispecies RBC lysis buffer, Thermo Fisher ebioscience, Waltham, MA, USA), incubated for 10 mins and neutralized by the addition of 2 mL PBS. After 2 washing steps, the pellet was resuspended in PBS and stained with fluorophore-labelled antibodies as described in the flow cytometry section. Flow cytometry was carried out using the same setup as for peripheral leukocytes.

Flow cytometry analysis

The leukocyte markers used in this pre-clinical study were selected to match the markers that are commonly utilized to (immunologically) characterize polytrauma patients [2427]; their selection also overlaps with corresponding animal studies [2830].

Fluorescence activated cell sorting (FACS) was performed on a FC500 flow cytometer (Beckman Coulter Life Sciences, United States of America). The software used for visualization and analysis of the data was RXP (Beckman Coulter Life Sciences, USA).

EDTA-anti-coagulated blood was diluted 1:2 with PBS and stained native before lysis to examine the cellular immune status of the animals. Fluorophore-labelled anti-mouse antibodies against CD11b (FITC-conjugated), Ly6-G (PE-Cy5-conjugated), MHC-II (PE-conjugated), CD4 (FITC-conjugated), CD8a (PE-Cy7-conjugated), CD127 (PE-conjugated) and CD25 (PE-Cy5-conjugated) were purchased from eBioscience (Thermo Fisher, Waltham, MA, USA), antibodies and samples were prepared according to the manufacturers guidelines. Subsets of leukocytes were first identified by their morphological appearance (FSC-SSC) and in a second step through positivity or negativity for the specific surface markers. Granulocytes were defined as CD11b+Ly6Ghigh-SSChigh, monocytes as CD11+Ly6Glow-SSClow. The expression of CD11b and MHC-II on those two cell subsets was monitored through the median fluorescence intensity of the respective antigens. FSC-SSClow cells were assigned as lymphocytes, CD4+CD25+CD127low cells as regulatory T-cells. T-helper cells were labelled as CD4+ and cytotoxic T-cells as CD8+. A schematic figure of the gating strategy to identify these subsets is provided in the supplementary material (S1 and S2 Figs).

Statistical analysis

All data sets were tested for normality before analysis. Abnormally distributed data were logarithmically transformed (Y = log(Y)) to achieve normal distribution if possible. Differences among the groups were evaluated using one-way ANOVA for normally distributed and Kruskal-Wallis test for non-parametric data. Bonferroni/Dunn's Multiple Comparison post-hoc tests were used for all figures to compare data in each strain at different time-points (i.e. control vs. 24h vs. 48h; each figure panel) and simultaneously between strains at corresponding time-points (e.g. 24h BALB/c vs. 24h CD-1). Significance level was set at p = 0.05.

Data variability between BALB/c and CD-1 mice was analyzed by variation coefficients for all investigated parameters, followed by student’s T-test to compare each time point.

All statistical tests were carried out using Graphpad (Prism, Software Inc., San Diego, USA)


Similar CD11b and Ly6G expression in inbred and outbred mice after trauma

BALB/c and CD-1 mice showed an increase of activated granulocytes (Ly6G+CD11b+) from 24h to 48h after trauma (p<0.05), but only in BALB/c this was preceded by a transient drop at 24h compared to baseline (p<0.05) (Fig 1).

<h2>Post-traumatic changes of Ly6G+CD11b+ granulocytes in peripheral blood.</h2>
Fig. 1.

Post-traumatic changes of Ly6G+CD11b+ granulocytes in peripheral blood.

3-month-old, female BALB/c and CD-1 mice underwent TSH (femur fracture, splenectomy and hemorrhagic shock): n = 35 at baseline, n = 10 at 24h and n = 15 at 48h. CD-1 mice: n = 18 at baseline, n = 10 at 24h and n = 5 at 48h. *p<0.05; §p<0.05 compared to all other time points from the same mouse strain.

Strain specific differences in CD4+CD25+CD127low regulatory T-cells

Trauma induced a gradual decrease in CD4+ and CD8+ T-lymphocytes (Fig 2A and 2B) in both strains. This decrease was less pronounced in CD4+ T-cells from BALB/c mice, while their CD8-T-cells decreased by 20% and 30% at 24h and 48h compared to control (p<0.05). The CD4+/CD8+-ratio was increased in BALB/c mice compared to CD-1 at 24h after trauma (Fig 2C). Regulatory T-cells (CD4+CD25+CD127low) were at least 1.5-fold higher in BALB/c mice at all time points (p<0.05) (Fig 3). However, independent of the strain, polytrauma induced a gradual increase of circulating CD4+CD25+CD127low cells over the 48h observation period; at 48h post-trauma, they were increased by 39% in BALB/c (p<0.05) and by 26% in CD-1 mice compared to baseline (Fig 3).

<h2>Post-traumatic alterations in circulating T-cell populations in peripheral blood.</h2>
Fig. 2.

Post-traumatic alterations in circulating T-cell populations in peripheral blood.

3-month-old, female BALB/c and CD-1 mice underwent TSH (femur fracture, splenectomy and hemorrhagic shock): (A) CD4+ and (B) CD8+ T-cells (C) CD4/CD8 ratio. BALB/c mice: n = 35 at baseline, n = 10 at 24h and n = 15 at 48h. CD-1 mice: n = 18 at baseline, n = 10 at 24h and n = 5 at 48h. *p< 0.05.

<h2>Post-traumatic alterations of CD4+CD25+CD127<sup>low</sup> regulatory T-cells in peripheral blood.</h2>
Fig. 3.

Post-traumatic alterations of CD4+CD25+CD127low regulatory T-cells in peripheral blood.

3-month-old, female BALB/c and CD-1 mice underwent TSH (femur fracture, splenectomy and hemorrhagic shock). BALB/c mice: n = 35 at baseline, n = 10 at 24h and n = 15 at 48h. CD-1 mice: n = 18 at baseline, n = 10 at 24h and n = 5 at 48h. *p< 0.05.

Trauma-induced alterations in the blood and bone marrow lymphocytes in BALB/c and CD-1 mice

Trauma induced a transient 36% drop in CD11b-Ly6G-MHC-2+ lymphocytes isolated from the blood at 24h after trauma only in BALB/c, while in CD-1 mice they remained at baseline level (p<0.05). BALB/c mice had a continuously higher blood level of MHC-2-expressing lymphocytes (CD11b-Ly6G-MHC-2+) by at least 1.8-fold (Fig 4A). In the bone marrow of CD-1 mice, MHC-2 expression on lymphocytes decreased by 40% within 48h of trauma. However, BALB/c bone marrow lymphocytes did not respond to trauma; at 48h the level of CD11b-Ly6G-MHC-2+ cells was 1.5-fold higher than the one detected in CD-1 mice (Fig 4B).

<h2>Alterations of MHC-2 expression on LY6G-CD11b- lymphocytes in the peripheral blood and the bone marrow.</h2>
Fig. 4.

Alterations of MHC-2 expression on LY6G-CD11b- lymphocytes in the peripheral blood and the bone marrow.

3 month old, female BALB/c and CD-1 mice underwent TSH (femur fracture, splenectomy and hemorrhagic shock). (A) MHC-2 expression on lymphocytes in the peripheral blood, BALB/c mice: n = 35 at baseline, n = 10 at 24h and n = 15 at 48h. CD-1 mice: n = 18 in control (healthy), n = 10 at 24h and n = 5 at 48h. (B) MHC-2 expression on lymphocytes in the bone marrow. BALB/c mice: n = 10 at baseline, n = 10 at 24h and n = 5 at 48h. CD-1 mice: n = 10 in control (healthy), n = 9 at 24h and n = 5 at 48h. *p<0.05; §p<0.05 compared to all other time points from the same mouse strain.

Less data variability in BALB/C mice at 24h

Data variability was analyzed using variation coefficients. BALB/c mice showed lower variability (0.15 vs. 0.38) of data at 24h after TSH (p<0.05). However, at baseline (control) and at 48h after trauma, variability was comparable between strains.


This (preliminary) study was conducted within the scope of a larger study with an overall aim to establish a composite poly-trauma hit including splenectomy and investigate its influence upon secondary sepsis. Based on the presented data (i.e. from the CD-1 versus BALB/C comparison), the BALB/c strain was selected for the main project [23]. We consider these comparative findings useful to researchers who employ mouse polytrauma models. Specifically, we subjected two of the most commonly used mouse strains, i.e. BALB/c (inbred) and CD-1 (outbred) to polytrauma (i.e. TSH) and compared selected leukocyte subpopulations in the blood and bone marrow compartments. The general trend in the posttraumatic leukocyte responses was similar between the two mouse strains; changes were only transiently more homogenous in BALB/c mice (i.e. at 24h post-TSH).

Polytrauma is one of the major causes of death in patients below 60 years [31,32]. If the severe injury itself is not immediately lethal, it can compromise the patients’ immune system predisposing them for complications such as secondary infections including sepsis. Numerous animal models have been employed over the years to experimentally recapitulate the most frequent clinical trauma sequelae including immunosuppression. Mice are within the widely accepted and preferably used model organisms to study immune reactions to such specific impacts due to their well-identified genetic background, the wide range of disposable surgical, technical and analytical methods, as well as their economic price. However, differences between the human and the murine immune/inflammatory response in the context of critical care medicine exist and have to be considered for an appropriate study design [3336]. E.g. in contrast to humans, mice have a higher percentage of lymphocytes [37], they lack MHC-2 expression on T-cells [38,39] and CD4 expression on macrophages [40]. Furthermore, rodents need to be subjected to a much greater injury severity to elicit immune dysfunctions comparable to those occurring in human trauma patients [33,41]. That is why an effective preclinical modeling of the abovementioned scenario (i.e. posttraumatic phenotype of diminished immunocompetence) requires complex combinations of various injurious elements (e.g. hemorrhagic shock, fractures, chest trauma, cecotomy, traumatic brain injury). To date, only few preclinical studies compared immune or inflammatory responses between inbred and outbred mice in critical care conditions such as trauma and/or infection [16,21,22,42], thus definitive conclusions regarding the leukocyte dynamics are difficult to reach. In the studies by Rai et al. [21,42], intravenous injection of Listeria monocytogenes or lymphocytic choriomeningitis virus (LCMV) resulted in a higher variation in the magnitude of the CD8 T-cell response in outbred mice (Swiss Webster) independent of the infectious challenge [21]. In outbred mice, the memory CD8 T-cell pool-size and expansion rate of CD8+ T-cells were more heterogeneous and the magnitude between the effector response and infection dose was much more variable and did not correlate with the release of inflammatory cytokines [42]. In our study, polytrauma resulted in a decrease of CD8+ T-cells in both strains, however this change was significant only in BALB/c mice. Although the expression of CD4 on T-cells was comparable between inbred and outbred mice, we always detected an increased level in the subpopulation of regulatory T-cells (CD4+CD25+CD127low) in BALB/c mice. Much more pronounced differences in immune reactions between inbred and outbred mouse strains were demonstrated in a burn trauma study by Ma et al. [20]. First, thermally-induced mucosal damage containing predominantly lymphocytes and neutrophils could be shown in BALB/c, but not in CD-1 and C57/BL6 mice. Additionally, bacterial translocation across the gut mucosa occurred in 74% of BALB/c, but only in 7% of CD-1 mice without demonstrating any inter-strain differences in the cecal microbiome [20].

Of note, it appears that differences in the immune cell composition do not only occur between inbred and outbred strains but e.g. also within inbred strains. For example, Chen et al. compared CD4+CD25+ Tregs between BALB/c and B/6 mouse strains and observed higher Tregs counts in BALB/c mice [43]. Such differences between two inbred strains also occurred in the study from Matsutani et al. [44], who stimulated splenocytes and bone marrow cells from C3H/HeN and C57BL/6J mice (subjected to trauma and hemorrhage) with Concavalin A and demonstrated that the genetic background resulted in differences in the proliferation rates and the release of cytokines.

Variation coefficients were lower in BALB/c mice compared to CD-1 only at 24h after trauma, which could be due to their more uniform genetic background [22]. Inbred strains have heterozygous call rates greater than 2% [45]. In contrast, e.g. Charles River Laboratories guarantees 28–29% heterozygosis for CD-1 mice [46]. However, it can be presumed that the approximate 30% heterozygosis in outbred mice does not appropriately reflect the larger heterozygosis characteristic of the human population. Although a higher percentage of heterozygosis as seen in outbred mice more likely represents the genetic variations seen in the human population, the solely use of outbred mice in the present study would not have provided additional information.


Our study showed that the immune responses to polytrauma were similar between inbred BALB/c and outbred CD-1 mice. BALB/c mice displayed a higher level of circulating regulatory T-cells and MHC-2-positive lymphocytes compared to CD-1 mice.

Supporting information

S1 Fig [a]

S2 Fig [tif]
Representative gating strategy for monocyte-derived macrophages and the polarization towards Arginase I and inducible NO synthase (iNOS) metabolism.

S1 Table [xls]
Experimental raw data generated by flow cytometry.


1. Worldwide Animal Statistics. In: Worldwide Animal Statistics [Internet]. Available:

2. European Commission. Seventh Report on the Statistics on the Number of Animals used for Experimental and ohter Scientific Purposes in the Member States of the European Union [Internet]. 2016. Available:

3. Johnson M. Laboratory Mice and Rats. Mater Methods. 2012;2. doi: 10-13070/mm.en.2.113

4. Casellas J. Inbred mouse strains and genetic stability: a review. animal. 2011;5: 1–7. doi: 10.1017/S1751731110001667 22440695

5. Festing MFW. Invited review: Inbred strains should replace outbred stocks in toxicology, safety testing, and drug development. Toxicol Pathol. 2010;38: 681–690. doi: 10.1177/0192623310373776 20562325

6. Srivastava A, Morgan AP, Najarian ML, Sarsani VK, Sigmon JS, Shorter JR, et al. Genomes of the Mouse Collaborative Cross. Genetics. 2017;206: 537–556. doi: 10.1534/genetics.116.198838 28592495

7. Chick JM, Munger SC, Simecek P, Huttlin EL, Choi K, Gatti DM, et al. Defining the consequences of genetic variation on a proteome-wide scale. Nature. 2016;534: 500–5. doi: 10.1038/nature18270 27309819

8. Nashef A, Agbaria M, Shusterman A, Lorè NI, Bragonzi A, Wiess E, et al. Dissection of Host Susceptibility to Bacterial Infections and Its Toxins. 2017. pp. 551–578. doi: 10.1007/978-1-4939-6427-7_27 27933544

9. Smith CM, Proulx MK, Olive AJ, Laddy D, Mishra BB, Moss C, et al. Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype. MBio. 2016;7. doi: 10.1128/mBio.01516-16 27651361

10. Winter JM, Gildea DE, Andreas JP, Gatti DM, Williams KA, Lee M, et al. Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. Cell Syst. 2017;4: 31–45.e6. doi: 10.1016/j.cels.2016.10.018 27916600

11. Brett SJ, Cox FE. Immunological aspects of Giardia muris and Spironucleus muris infections in inbred and outbred strains of laboratory mice: a comparative study. Parasitology. 1982;85 (Pt 1): 85–99. Available:

12. Ehrnthaller C, Huber-Lang M, Kovtun A, Rapp AE, Kemmler J, Gebhard F, et al. C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing. Eur J Med Res. 2016;21: 42. doi: 10.1186/s40001-016-0236-7 27784330

13. Jensen VS, Porsgaard T, Lykkesfeldt J, Hvid H. Rodent model choice has major impact on variability of standard preclinical readouts associated with diabetes and obesity research. Am J Transl Res. 2016;8: 3574–84. 27648148

14. Lueker DC, Helper DI. Differences in immunity to Nematospiroides dubius in inbred and outbred mice. J Parasitol. 1975;61: 158–9. 1167907

15. Morgan AP, Fu C-P, Kao C-Y, Welsh CE, Didion JP, Yadgary L, et al. The Mouse Universal Genotyping Array: From Substrains to Subspecies. G3&#58; Genes|Genomes|Genetics. 2016;6: 263–279. doi: 10.1534/g3.115.022087 26684931

16. Richardson SH, Kuhn RE. Studies on the genetic and cellular control of sensitivity to enterotoxins in the sealed adult mouse model. Infect Immun. 1986;54: 522–8. 3533783

17. Turnbull IR, Ghosh S, Fuchs A, Hilliard J, Davis CG, Bochicchio G V., et al. Polytrauma Increases Susceptibility to Pseudomonas Pneumonia in Mature Mice. SHOCK. 2016;45: 555–563. doi: 10.1097/SHK.0000000000000538 26863126

18. Winston CN, Noël A, Neustadtl A, Parsadanian M, Barton DJ, Chellappa D, et al. Dendritic Spine Loss and Chronic White Matter Inflammation in a Mouse Model of Highly Repetitive Head Trauma. Am J Pathol. 2016;186: 552–567. doi: 10.1016/j.ajpath.2015.11.006 26857506

19. Bricker-Anthony C, Rex TS. Neurodegeneration and Vision Loss after Mild Blunt Trauma in the C57Bl/6 and DBA/2J Mouse. Lewin AS, editor. PLoS One. 2015;10: e0131921. doi: 10.1371/journal.pone.0131921 26148200

20. Ma L, Ma J-W, Deitch EA, Specian RD, Berg RD. Genetic Susceptibility to Mucosal Damage Leads to Bacterial Translocation in a Murine Burn Model. J Trauma Inj Infect Crit Care. 1989;29: 1245–1251. doi: 10.1097/00005373-198909000-00010 2769809

21. Rai D, Pham N-LL, Harty JT, Badovinac VP. Tracking the Total CD8 T Cell Response to Infection Reveals Substantial Discordance in Magnitude and Kinetics between Inbred and Outbred Hosts. J Immunol. 2009;183: 7672–7681. doi: 10.4049/jimmunol.0902874 19933864

22. Cahill LS, Laliberté CL, Liu XJ, Bishop J, Nieman BJ, Mogil JS, et al. Quantifying Blood-Spinal Cord Barrier Permeability after Peripheral Nerve Injury in the Living Mouse. Mol Pain. 2014;10: 1744-8069-10–60. doi: 10.1186/1744-8069-10-60 25216623

23. Drechsler S, Zipperle J, Rademann P, Jafarmadar M, Klotz A, Bahrami S, et al. Splenectomy modulates early immuno-inflammatory responses to trauma-hemorrhage and protects mice against secondary sepsis. Sci Rep. 2018;8: 1–12. doi: 10.1038/s41598-017-17765-5

24. Vester H, Dargatz P, Huber-Wagner S, Biberthaler P, Van Griensven M. HLA-DR expression on monocytes is decreased in polytraumatized patients. Eur J Med Res. 2015;20: 1–9. doi: 10.1186/s40001-014-0074-4

25. Menges T, Engel J, Welters I, Wagner R-M, Little S, Ruwoldt R, et al. Changes in blood lymphocyte populations after multiple trauma. Crit Care Med. 1999;27: 733–740. doi: 10.1097/00003246-199904000-00026 10321662

26. Venet F, Chung C-S, Kherouf H, Geeraert A, Malcus C, Poitevin F, et al. Increased circulating regulatory T cells (CD4+CD25+CD127−) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2009;35: 678–686. doi: 10.1007/s00134-008-1337-8 18946659

27. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, et al. Increased CD4+ CD25+ T Regulatory Cell Activity in Trauma Patients Depresses Protective Th1 Immunity. Trans. Meet Am Surg Assoc. 2006;124: 179–188. doi: 10.1097/01.sla.0000239031.06906.1f 16998360

28. Gentile LF, Nacionales DC, Cuenca AG, Armbruster M, Ungaro RF, Abouhamze AS, et al. Identification and description of a novel murine model for polytrauma and shock. Crit Care Med. 2013;41: 1075–1085. doi: 10.1097/CCM.0b013e318275d1f9 23399937

29. Dai H, Sun T, Liu Z, Zhang J, Zhou M. The imbalance between regulatory and IL-17-secreting CD4+T cells in multiple-trauma rat. Injury. 2013;44: 1521–1527. doi: 10.1016/j.injury.2013.03.015 23618785

30. Choileain NN, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced Regulatory T Cell Activity Is an Element of the Host Response to Injury. J Immunol. 2006;176: 225–236. doi: 10.4049/jimmunol.176.1.225 16365414

31. Kong LB, Lekawa M, Navarro RA, McGrath J, Cohen M, Margulies DR, et al. Pedestrian-motor vehicle trauma: an analysis of injury profiles by age. J Am Coll Surg. 1996;182: 17–23. 8542084

32. Pfeifer R, Teuben M, Andruszkow H, Barkatali BM, Pape H-C. Mortality Patterns in Patients with Multiple Trauma: A Systematic Review of Autopsy Studies. PLoS One. 2016;11: e0148844. doi: 10.1371/journal.pone.0148844 26871937

33. Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, Cuenca AG, et al. A better understanding of why murine models of trauma do not recapitulate the human syndrome. Crit Care Med. 2014;42: 1406–1413. doi: 10.1097/CCM.0000000000000222 24413577

34. Li P, Tompkins RG, Xiao W. KERIS: kaleidoscope of gene responses to inflammation between species. Nucleic Acids Res. 2017;45: D908–D914. doi: 10.1093/nar/gkw974 27789704

35. Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172: 2731–8. doi: 10.4049/jimmunol.172.5.2731 14978070

36. Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, Aibiki M, et al. Abandon the Mouse Research Ship? Not Just Yet! Shock. 2014;41: 463–475. doi: 10.1097/SHK.0000000000000153 24569509

37. Doeing DC, Borowicz JL, Crockett ET. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol. 2003;3: 1–6. doi: 10.1186/1472-6890-3-1

38. Barnaba V, Watts C, de Boer M, Lane P, Lanzavecchia A. Professional presentation of antigen by activated human T cells. Eur J Immunol. 1994;24: 71–75. doi: 10.1002/eji.1830240112 7517364

39. Denton MD, Geehan CS, Alexander SI, Sayegh MH, Briscoe DM. Endothelial Cells Modify the Costimulatory Capacity of Transmigrating Leukocytes and Promote Cd28-Mediated Cd4 + T Cell Alloactivation. J Exp Med. 1999;190: 555–566. doi: 10.1084/jem.190.4.555 10449526

40. Crocker PR. Species heterogeneity in macrophage expression of the CD4 antigen. J Exp Med. 1987;166: 613–618. doi: 10.1084/jem.166.2.613 3110358

41. Mira JC, Nacionales DC, Loftus TJ, Ungaro R, Mathias B, Mohr AM, et al. Mouse Injury Model of Polytrauma and Shock. 2018. pp. 1–15. doi: 10.1007/978-1-4939-7526-6_1 29468579

42. Martin MD, Danahy DB, Hartwig SM, Harty JT, Badovinac VP. Revealing the Complexity in CD8 T Cell Responses to Infection in Inbred C57B/6 versus Outbred Swiss Mice. Front Immunol. 2017;8. doi: 10.3389/fimmu.2017.01527 29213267

43. Chen X. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. J Leukoc Biol. 2005;78: 114–121. doi: 10.1189/jlb.0604341 15845645

44. Matsutani T, Anantha Samy TS, Kang SC, Bland KI, Chaudry IH. Mouse genetic background influences severity of immune responses following trauma-hemorrhage. Cytokine. 2005;30: 168–176. doi: 10.1016/j.cyto.2004.12.019 15863390

45. Rau CD, Parks B, Wang Y, Eskin E, Simecek P, Churchill GA, et al. High-Density Genotypes of Inbred Mouse Strains: Improved Power and Precision of Association Mapping. G3&#58; Genes|Genomes|Genetics. 2015;5: 2021–2026. doi: doi:10.1534/g3.115.020784

46. Charles River International (2011) CD-1 IGS Mice Nomenclature: Crl:CD1(ISG) [Internet]. 2011. Available:

Článok vyšiel v časopise


2019 Číslo 9

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…


Zvýšte si kvalifikáciu online z pohodlia domova

Faktory ovlivňující léčbu levotyroxinem
nový kurz

Kurz originály vs. generika

Autori: MUDr. Petr Výborný, CSc., FEBO

Autori: MUDr. Jiří Horažďovský, Ph.D

Klinická farmakokinetika betablokátorů

Všetky kurzy
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.


Nemáte účet?  Registrujte sa